Kaempferol ameliorates aflatoxin B1 (AFB1) induced hepatocellular carcinoma through modifying metabolizing enzymes, membrane bound ATPases and mitochondrial TCA cycle enzymes
- Author:
Langeswaran Kulanthaivel
;
Revathy Rajendran
;
Kumar Gowtham Subbaraj
;
Vijayaprakash Shanmugam
;
Balasubramanian Periyasamy Maruthaiveeran
- Publication Type:Journal Article
- Keywords:
Liver cancer;
Aflatoxins;
Kaempferol;
ATPase;
Carbohydrate metabolism enzymes;
TCA cycle enzymes;
Citric acid cycle enzymes
- From:Asian Pacific Journal of Tropical Biomedicine
2012;(z3):1653-1659
- CountryChina
- Language:Chinese
-
Abstract:
Objective: The present study was aimed to scrutinize the anticancer consequence of kaempferol against aflatoxin B1 induced hepatocarcinogenesis. Epidemiological studies of the incidence of liver cancer in the population, where dietary aflatoxin exposure is high, have provided much circumstantial evidence for the development of aflatoxin B1 induced primary liver cancer in humans. Methods:In the present investigation, aflatoxin B1 (2 mg/kg body weight i.p) was used as a hepatocarcinogen to induce hepatocellular carcinoma in experimental animals. Results: In the present analysis, on treatment with bioflavonoid kaempferol (100 mg/kg body weight p.o) the nucleic acids levels were brought back to normal and also the altered levels of biological enzymes such as membrane bound ATPase, carbohydrate metabolizing enzymes and mitochondrial TCA cycle enzymes levels (P<0.01).Conclusions:Membrane bound ATPase, carbohydrate metabolizing enzymes and mitochondrial TCA cycle enzymes were modulated by kaempferol evaluated on aflatoxin B1 induced primary liver carcinogenesis.
